GlassScriptPhysician profile
Denise Lopez
NPI 1497227821
$922.54
in general payments reported to CMS, 2019-2025
13 companies · $17.80 in 2025
The $17.80 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.20 · 2022: $423 · 2023: $433 · 2024: $24.82 · 2025: $17.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $236.14 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $129.80 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $129.69 | 2022-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $117.21 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.84 | 2022-2023 | |
| Amgen INC. | $51.04 | 2023 | Prolia, Evenity, Otezla |
| Otsuka America Pharmaceutical, INC. | $35.12 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.77 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.44 | 2022-2023 | Eliquis |
| Paratek Pharmaceuticals, INC. | $24.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.83 | 2022 | |
| Abbott Laboratories | $13.56 | 2023 | Freestyle Libre 3 |
| Qiagen, LLC | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.